Surge (Decision/Risk Analysis) Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 23

Employees

  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $8.16M

  • Investors
  • 17

Surge (Decision/Risk Analysis) General Information

Description

Developer of an immune profiling platform intended to enable precision medicine before surgery. The company's platform utilizes an immunological model using a proprietary machine-learning algorithm to combine single-cell assessment of the immune system before surgery with clinical data available through electronic health records to predict post-operative infections with higher accuracy, enabling surgeons to predict the patient's readiness and risk for surgical complications.

Contact Information

Website
www.surge.care
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1 Rue Des Soeurs
  • 67400 Illkirch-Graffenstaden
  • France
Primary Industry
Decision/Risk Analysis
Vertical(s)
Big Data, Artificial Intelligence & Machine Learning, HealthTech
Corporate Office
  • 1 Rue Des Soeurs
  • 67400 Illkirch-Graffenstaden
  • France

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Surge (Decision/Risk Analysis) Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Early Stage VC 27-Mar-2024 $8.16M Completed Generating Revenue
9. Accelerator/Incubator Completed Generating Revenue
8. Accelerator/Incubator Completed Generating Revenue
7. Early Stage VC 22-Sep-2022 Completed Generating Revenue
6. Accelerator/Incubator 01-Jan-2022 Completed Generating Revenue
5. Accelerator/Incubator Completed Generating Revenue
4. Grant 07-Apr-2021 Completed Generating Revenue
3. Grant 01-Jan-2021 Completed Startup
2. Accelerator/Incubator Completed Startup
1. Accelerator/Incubator Completed Startup
To view Surge (Decision/Risk Analysis)’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Surge (Decision/Risk Analysis) Patents

  • 3

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 1

    Pending

  • Expiring in next 12 mo

Surge (Decision/Risk Analysis) Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4343775-A1 A method for determining a medical outcome for an individual, related electronic system and computer program Inactive 22-Sep-2022
EP-4591316-A1 A method for determining a medical outcome for an individual, related electronic system and computer program Pending 22-Sep-2022
WO-2024062123-A1 A method for determining a medical outcome for an individual, related electronic system and computer program Inactive 22-Sep-2022 G16H50/20

Surge (Decision/Risk Analysis) Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Surge (Decision/Risk Analysis) Investors (17)

Investor Name Investor Type Holding Investor Since Participating Rounds
50 Partners Accelerator/Incubator Minority
Bpifrance Sovereign Wealth Fund Minority
Eurazeo Asset Manager Minority
Kima Ventures Venture Capital Minority
MH Innov' Corporate Venture Capital Minority
You’re viewing 5 of 17 investors. Get the full list »

Ready to get started?

Request a free trial

Surge (Decision/Risk Analysis) FAQs

  • When was Surge (Decision/Risk Analysis) founded?

    Surge (Decision/Risk Analysis) was founded in 2021.

  • Where is Surge (Decision/Risk Analysis) headquartered?

    Surge (Decision/Risk Analysis) is headquartered in Illkirch-Graffenstaden, France.

  • What is the size of Surge (Decision/Risk Analysis)?

    Surge (Decision/Risk Analysis) has 23 total employees.

  • What industry is Surge (Decision/Risk Analysis) in?

    Surge (Decision/Risk Analysis)’s primary industry is Decision/Risk Analysis.

  • Is Surge (Decision/Risk Analysis) a private or public company?

    Surge (Decision/Risk Analysis) is a Private company.

  • What is the current valuation of Surge (Decision/Risk Analysis)?

    The current valuation of Surge (Decision/Risk Analysis) is .

  • What is Surge (Decision/Risk Analysis)’s current revenue?

    The current revenue for Surge (Decision/Risk Analysis) is .

  • How much funding has Surge (Decision/Risk Analysis) raised over time?

    Surge (Decision/Risk Analysis) has raised $10.8M.

  • Who are Surge (Decision/Risk Analysis)’s investors?

    50 Partners, Bpifrance, Eurazeo, Kima Ventures, and MH Innov' are 5 of 17 investors who have invested in Surge (Decision/Risk Analysis).

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process